Relation Between Soluble Adhesion Molecules and Insulin Sensitivity in Type 2 Diabetic Individuals
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (11) , 1961-1966
- https://doi.org/10.2337/diacare.24.11.1961
Abstract
OBJECTIVE—The purpose of this study was to explore the relation between insulin resistance and plasma levels of soluble adhesion molecules and to examine the effects of acute hyperinsulinemia on these molecules in type 2 diabetic individuals. RESEARCH DESIGN AND METHODS—Intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and E- and P-selectin plasma concentrations were measured in 36 nonobese type 2 diabetic patients without cardiovascular disease and in 7 healthy subjects. Insulin sensitivity was assessed by a 4-h euglycemic (∼5 mmol/l)-hyperinsulinemic (∼300 pmol/l) clamp performed in combination with [3H]3-d-glucose infusion. RESULTS—Diabetic subjects were insulin resistant but did not show plasma concentrations of adhesion molecules that were significantly higher than control subjects. In diabetic subjects, plasma ICAM-1 and E-selectin were negatively correlated with total glucose disposal during the insulin clamp (r = −0.432, P < 0.01; and r = −0.375, P < 0.05, respectively), whereas plasma VCAM-1 and P-selectin were not. Plasma ICAM-1 as well as E- and P-selectin were positively correlated with BMI, total body fat (TBF), and waist girth (P < 0.05–0.001). In multiple regression analyses, the relation of plasma ICAM-1 and E-selectin with insulin sensitivity was lost after adjustment for potential confounders, including HbA1c, blood pressure, and/or LDL cholesterol. In these analyses, BMI was the only independent predictor of plasma ICAM-1 (R2 = 0.244, P < 0.002), whereas TBF was the only independent predictor of plasma E-selectin (R2 = 0.202, P = 0.01). The 4-h insulin infusion during the glucose clamp did not significantly change plasma levels of adhesion molecules. CONCLUSIONS—Overall adiposity, rather than insulin resistance, may be a determinant of plasma levels of ICAM-1 and E-selectin in type 2 diabetic individuals. In these patients, acute hyperinsulinemia does not exert any significant effect on plasma adhesion molecules. These findings support the possibility that adipose tissue releases one or more factors that may adversely affect endothelial function on one hand and insulin sensitivity on the other.Keywords
This publication has 27 references indexed in Scilit:
- Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 DiabetesTrends in Endocrinology & Metabolism, 2000
- Effects of Hyperinsulinemia on Plasma Levels of Circulating Adhesion MoleculesJournal of Clinical Endocrinology & Metabolism, 2000
- Cell Adhesion Molecules in Cardiovascular Disease and Its Risk Factors--What Can Soluble Levels Tell Us?Journal of Clinical Endocrinology & Metabolism, 2000
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Effect of Chronic Treatment with Lacidipine or Lisinopril on Intracellular Partitioning of Glucose Metabolism in Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1999
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.Journal of Clinical Investigation, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993